BMS-814580 是一种具有口服活性的高效 MCHR1 抑制剂,Ki 值为 16.9 nM,并具有抗肥胖活性。
产品编号: MS-Y69464 CAS No.: 1197420-11-3 分子式: C24H19ClF2N2O4S 分子量: 504.93
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

BMS-814580 是一种具有口服活性的高效 MCHR1 抑制剂,Ki 值为 16.9 nM,并具有抗肥胖活性。

生物实验数据

生物活性 BMS-814580 is an orally active and highly potent MCHR1 inhibitor with a Ki value of 16.9 nM, exhibiting anti-obesity activity.
IC50 & Target

Ki: 16.9 nM (MCHR1)

体外研究
(In Vitro)

BMS-814580 (3.0 μM; 10 min) shows stability with 90%, 95% and 100% remaining in human, rat and mouse liver microsomes, respectively.
BMS-814580 displays modest in vitro ion channel inhibition of 43%, 21%, and 15%, respectively, for hERG, Na (4 Hz), and L-type Ca channels at 10 μM.

体内研究
(In Vivo)

BMS-814580 (0-3 mg/kg; p.o.; once daily for 28 days) shows antiobesity activities in rats.

Animal Model: Obese male SD rats, chronic diet-induced obese (DIO) rat model
Dosage: 0.03, 0.1, 0.3, 1 and 3 mg/kg
Administration: Orally administered as the phosphate prodrug, once daily for 28 days
Result: Dose dependently reduced body weight.
Animal Model: Sprague-Dawley Rats
Dosage: 10 mg/kg
Administration: Oral administration, once
Result: Pharmacokinetics (PK) and Pharmacodynamics (PD) Data: Plasma and Brain Concentrations of Cyclic Tertiary Alcohols and the Effect on Body Weights in Sprague-Dawley Rats
8 h rat PK studyb 4-day PD studyc day 4 parent compd concn at 20 h
compd dosed asa AUC (μM•h) brain (nM) plasma (nM) % weight loss brain (nM) plasma (nM)
BMS-814580 glycinate 38.1 11330 4500 6.4d 7955 12801

aRats were dosed orally with parent compound or a prodrug; prodrugs doses were adjusted to parent compounds. Vehicle = 0.5% Methocel, 0.1% Tween 80, 99.4% distilled water. bDose = 10 mg/kg; plasma and brain concentrations are reported 8 h after dose, n = 2. cCompounds were dosed at 3, 10, and 30 mg/kg orally once a day for 4 days; weight loss data is reported only for the 10 mg/kg dose, n = 8; reduction in body weight is reported as % change from baseline body weight compared to vehicle treated animals. NT = not tested. dNo biliary lesions were seen in this model.
Animal Model: Sprague-Dawley Rats
Dosage: 10 mg/kg (phosphate prodrug) or 1 mg/kg
Administration: Oral (phosphate prodrug) or intravenous administration (Pharmacokinetic Analysis)
Result: Pharmacokinetics Data for BMS-814580 in Rata
species compd (mg/kg) route of admin Cmax (μM) Tmax (h) AUC0−∞ (μM•h) T1/2 (h) CL (mL/min/kg) Vss(L/kg) F (%)
rat BMS-814580 (1) iv 11.5 >24 0.9 4.1
BMS-814580 phosphate (10) po 4.0 6.7 107 54

aVehicles: iv, PEG400/DMAC/water (70:5:25); po, Methocel/Tween80/water (0.5:0.1:99.4).

化学信息

分子量 504.93
分子式 C24H19ClF2N2O4S
CAS No. 1197420-11-3

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础